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Community Health Behaviors and Geographic Variation
in Early-Onset Colorectal Cancer Survival Among Women
Andreana N. Holowatyj, PhD, MS1,2,3, Marvin E. Langston, PhD, MPH4, Yunan Han, MD5, Richard Viskochil, MS, PhD3,6,
Jose Perea, MD, PhD7, Yin Cao, MPH, ScD5,8, Charles R. Rogers, PhD, MPH, MS9, Christopher H. Lieu, MD10 and
Justin X. Moore, PhD, MPH11
INTRODUCTION: Despite overall reductions in colorectal cancer (CRC)morbidity andmortality, survival disparities by sex
persist among young patients (age <50 years). Our study sought to quantify variance in early-onset CRC
survival accounted for by individual/community-level characteristics among a population-based cohort
of US women.
METHODS: Geographic hot spots—countieswithhigh early-onset CRCmortality rates amongwomen—were derived
using 3 geospatial autocorrelation approaches with Centers for Disease Control and Prevention national
mortality data. We identified women (age: 15–49 years) diagnosed with CRC from 1999 to 2016 in the
National Institutes of Health/National Cancer Institute’s Surveillance, Epidemiology, and End Results
program. Patterns of community health behaviors by hot spot classificationwere assessed by Spearman
correlation (r). GeneralizedR2 values were used to evaluate variance in survival attributed to individual/
community-level features.
RESULTS: Approximately 1 in every 16 contiguousUS counties identified as hot spots (191 of 3,108), and 52.9%
of hot spot counties (n5 101) were located in the South. Among 28,790 women with early-onset CRC,
13.7% of cases (n 5 3,954) resided in hot spot counties. Physical inactivity and fertility were
community health behaviors thatmodestly correlated with hot spot residence among women with early-
onset CRC (r 5 0.21 and r 5 20.23, respectively; P < 0.01). Together, individual/community-level
features accounted for distinct variance patterns in early-onset CRC survival among women (hot spot
counties: 33.8%; non–hot spot counties: 34.1%).
DISCUSSION: Individual/community-level features accounted for approximately one-third of variation in early-onset
CRC survival amongwomen anddiffered between hot spot vs non–hot spot counties. Understanding the
impact of community health behaviors—particularly in regions with high early-onset CRC mortality
rates—is critical for tailoring strategies to reduce early-onset CRC disparities.
SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/CTG/A446; http://links.lww.com/CTG/A447; and http://links.lww.com/CTG/A448.
Clinical and Translational Gastroenterology 2020;11:e00266. https://doi.org/10.14309/ctg.0000000000000266
INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer and
the third leading cause of cancer deaths among women and men
in the United States, with an estimated 147,950 new cases and
53,200 deaths in 2020 (1). Despite reductions in the overall CRC
burden, incidence rates are rising at an alarming rate with un-
known etiologies for men and women younger than 50 years
(2–4). Initial studies support the role of health behaviors in early-
onset colorectal carcinogenesis—as obesity, physical inactivity,
and sedentary behaviors have been linked to increased early-
onset CRC risk among women (5–7). However, the role of health
behaviors on CRC outcomes among young women remains un-
known. Given that sex disparities in survival among patients
with early-onset CRC have been previously reported (3), a
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better understanding of sex-specific differences in colorectal
carcinogenesis—particularly among young patients—is needed
to optimize detection and treatment strategies.
Sex differences in disease prevalence and outcomes persist
among all-comers diagnosed with CRC. Women have a higher
incidence of right-sided CRCs (8,9), and women with right-sided
tumors tend to exhibit a higher rate of comorbidities (9). Lie-
berman et al. observed an association between proximal large
polyp risk and female sex (10), although the prevalence of polyps
among young patients with CRC remains unknown. Importantly,
sex differences in the performance of fecal occult blood testing
and colonoscopies have been reported by sex (11,12) because
colonoscopy is considered to be amore difficult procedure among
women. Previous reports have indicated that approximately one-
third of colonoscopies performed in women were considered
technically difficult vs only 1 in every 6 cases amongmen (12). As
differences in colon length, body fatness, energy balance, and
secretion of hormones in proportion to fat also persist by sex
(12,13), these findings suggest that differences in tumor biology
and individual health behaviors may be associated with sex-
specific disparities in CRC outcomes—particularly among young
patients.
Given the impact of sex-specific differences on CRC pre-
sentation and prognosis (1,3), we hypothesize that biological-,
individual-, and community-level factors may be contributing to
sex-specific disparities in disease-specific outcomes, as well as
distinct patterns in geographic variation of early-onset CRC
survival by sex. The purpose of our population-based cohort
study was to define county-level early-onset CRC mortality hot
spots among women using geospatial methodology and to de-
termine the contribution of individual- and community-level
characteristics on geographic variation in CRC-specific survival
among women diagnosed with a first primary invasive CRC aged
15–49 years—using nationally representative data from the
Centers for Disease Control and Prevention (CDC) and National
Institutes of Health/National Cancer Institute’s Surveillance,
Epidemiology, and End Results (SEER) Program.
METHODS
Early-onset CRC hot spots
Data were obtained from the CDC underlying causes of death file
which collects national mortality data for every US resident (14),
and from the National Institutes of Health/National Cancer In-
stitute’s SEER Program, which collects cancer incidence/
mortality data from 18 population-based (Figure 1) cancer reg-
istries covering approximately 28% of the US population (15)
(Figure 1). Early-onset CRCs were defined as cancers of the colon
and rectum diagnosed among women aged 15–49 years. National
mortality data from theCDCbetween years 1980 and 2018within
the contiguous United States were used to examine early-onset
CRC mortality (on the basis of available death certificate in-
formation) among women aged 15–54 years (to identify women
with early-onset CRC [age ,50 years] with standardized 5-year
follow-up) by county-level estimates using geospatial method-
ology as we have previously described (16).
Geographic hot spots—counties of high mortality rates for
early-onset CRC—were derived using 3 geospatial methods.
First, we estimated the smoothed Empirical Bayes (EB) early-
onset CRC mortality rates using the proportion of women with
deaths attributed to CRC, with smoothing performed using the
EB tools in GeoDa1.6.7.9 (http://geodacenter.asu.edu) (17).
Briefly, the smoothed EB rate method allows for more stable
estimation of CRC mortality rates by accounting for the overall
county population. EB smoothing includes the variance of each
county by using the corresponding county population, and thus,
counties with higher populations have smaller variance while
those with smaller populations have larger variance. Further-
more, the EB rates are smoothed using an inverse function of the
variance for shrinkage toward the overall mean for early-onset
CRC mortality rates (e.g., counties with larger populations and
smaller variance gave higher weights toward the observed
weights). We categorized the EB smoothed early-onset CRC
mortality rates into quintiles, and we defined counties as high-
risk if the smoothed EB early-onset CRC mortality rates for
women were in the fifth quintile. Second, we used Local Indi-
cators of Spatial Association tomeasure similarity of early-onset
CRC mortality between counties and calculate values both
within and across geographic boundaries, additionally identi-
fying spatial outliers (17–19). For each US county, we estimated
Local Moran’s I Statistic values, using associated z-scores and P
values to assess the magnitude of spatial autocorrelation and
statistical significance, respectively (17). Statistically significant
positive z-scores indicated counties surrounded by areas with
similar early-onset CRC mortality rates for women—either
similarly high or similarly low (positive spatial autocorrelation)
(17). Finally, we used theGetis-OrdGi* statistic to identify areas
where early-onset CRC mortality rates with either high or low
values clustered within the context of the neighboring county
(17,20–22). To estimate the Gi* statistic, we used age-adjusted
early-onset CRC mortality rates.
We considered a county to be a “hot spot” for early-onset CRC
among women if it was identified as high risk using the following
3 geospatial analyses: (i) fifth quintile of smoothed EB early-onset
CRCmortality rates, (ii) high-high cluster using Local Indicators
of Spatial Association, and (iii) as defined by Getis-Ord Gi* sta-
tistic. All other US counties were categorized as non–hot spots.
Therefore, “hot spots” were defined conservatively to represent
areas of high early-onset CRCmortality amongwomen using all 3
approaches (see Table S1, Supplementary Digital Content 1,
http://links.lww.com/CTG/A446).
Study population
A case listing was run on the SEER 18 Registries Custom Data
with additional treatment fields data set (SEER*Stat 8.3.6) (15) to
obtain clinicodemographic and survival data on first primary
invasive early-onset CRC cases. Analysis was restricted to include
28,790 women diagnosed between years 1999 and 2016 in the
contiguous United States with known age and race/ethnicity
classified as non-Hispanic white, non-Hispanic black (NHB),
Hispanic, Asian/Pacific Islander, American Indian/Alaska Na-
tive, or unknown (Figure 1). Demographic and clinical charac-
teristics examined included diagnosis age, race/ethnicity, county
of CRC diagnosis, marital status, American Joint Committee on
Cancer (AJCC) clinical stage, tumor site (colon or rectosigmoid
junction/rectum), histopathologic subtype, cancer sequence, re-
ceipt of surgery, chemotherapy, and radiation therapy. Receipt of
surgery, chemotherapy, and radiation therapy as part of first
course of treatmentwere each evaluated as dichotomous variables
(yes or no/unknown). Survival time was calculated from di-
agnosis date to last follow-up or death date. Follow-up for each
patient is current within 22months of the annual submission date
(November 2018).






SEER data linkage to CDC, American Community Survey, and
County Health Rankings databases
To obtain characteristics on community-level health behaviors,
SEER cases were linked with CDC data, as well as data from the
2014 County Health Rankings (CHR) and the 2014 American
Community Survey (ACS)—by Federal Information Processing
Standard county codes (Figure 1). The CHR and ACS comprise
nationally representative data collected from a sample of the total
noninstitutionalized population aged 181 years residing in
households. The CHR database uses several survey samples (e.g.,
Food Environment Atlas) to provide estimates of county-level
factors, and the ACS provides aggregated estimates for de-
mographic statistics over 5 years (2014 ACS: years 2010–2014).
From the 2014 CHR, we considered the county-level pro-
portions of adult obesity (individuals aged 201 years who report
a body mass index 301 kg/m2), adult smoking (adult population
that currently smokes daily or most days and has smoked 1001
cigarettes in their lifetime), fertility (women aged 15–50 years
with a live birth in the past year), foreign born individuals, limited
access to healthy foods (population that is low income [having an
annual family income#200% of the federal poverty threshold for
the family size] and does not live close to a grocery store [rural
areas: 101 miles; nonrural: 11 miles from a grocery store]),
physical inactivity (adults [age: 201 years] reporting no leisure-
time physical activity), unemployment (civilian labor force aged
161 years unemployed but seekingwork), uninsured (population
aged 18–65 years with no health insurance coverage), and pri-
mary care physicians (ratio of primary care physicians per
100,000 persons).
From the 2014 ACS, we collected county-level proportions for
the following demographic characteristics: race/ethnicity (non-
Hispanic white, NHB, or Hispanic), household income, and
population density. Population density was evaluated as a di-
chotomous variable (rural/urban) as previously described (16)
using 2010 Rural-Urban Commuting Area classifications: Urban
areas were defined as population centers with 50,0001 residents
and rural/nonurban areas were defined as towns or small cities
with population centers with fewer than 50,000 residents.
Statistical analysis
Differences in clinicodemographic characteristics by CRC mor-
tality rate regions (hot spot vs non–hot spot counties) were
compared using x2 tests for categorical variables and ANOVA or
Wilcoxon rank-sum tests for continuous variables as appropriate.
Multilevel regression models were used to investigate hot spot
associations with CRC-specific survival. Cox proportional haz-
ardsmodels were used to assess hazard ratios and 95% confidence
intervals for hot spot classification, age at diagnosis (5-year
groups), race/ethnicity, tumor site, AJCC clinical stage, histo-
pathologic subtype, and surgery in adjusted models.
Multivariable-adjusted models were adjusted for individual-level
clinicodemographic features that reached statistical significance
in bivariate analysis (P , 0.05) and county-level sociodemo-
graphic factors with Spearman correlations r$ |0.20|, as well as
the proportion of the population with household income
,$20,000 annually (as a proxy for socioeconomic status) with
early-onset CRC hot spot residence. We tested the proportional
hazards assumption in the multivariate model for CRC-specific
survival by adding an interaction termwith hot spot classification
and follow-up time to the final models. Generalized R2 values
were calculated to quantify the variance in early-onset CRC
survival accounted for by individual-level clinicodemographic
and county-level sociodemographic characteristics, and total
variance accounted for by these features, using Cox proportional
hazards regression. All data were analyzed using SAS v9.4 sta-
tistical software (SAS Institute, Cary, NC) and GeoDa v1.6.7.9
software. ArcGIS v10.5 geospatial processing softwarewas used to
visualize the geographic distribution of primary invasive early-
onset CRC cases among women by hot spot classification. Sta-
tistical tests were 2-sided, with P , 0.05 considered to be statis-
tically significant.
RESULTS
To define areas of high early-onset CRC mortality (hot spots)
among women, we created a composite hot spot map with
3 geospatial analyses using CDC national mortality data
(Figure 2). Approximately 1 in every 16 contiguous US counties
identified as hot spots (191 of 3,108), and 52.9% of hot spot
counties among women (n 5 101) were located in the Southern
region of the United States (Figure 2 and see Table S1, Supple-
mentary Digital Content 1, http://links.lww.com/CTG/A446).
Using SEER, we identified a total of 28,790 female early-onset
CRC cases between 1999 and 2016. Linkage of cases with geo-
graphic data by Federal Information Processing Standard county
codes revealed that approximately 1 in every 7 women (13.7%)
with early-onset CRC resided in hot spot counties (Table 1). Race/
ethnicity, stage, histopathology, and receipt of first-course ther-
apies significantly differed by hot spot residence (P # 0.001;
Table 1). NHBs accounted for nearly one-quarter of early-onset
CRC cases among women in hot spot counties (23.7%) compared
with 14.3% of all early-onset CRC cases among women in non–
hot spot counties (P, 0.0001).More than one-third of all women
diagnosed with early-onset CRC had tumors of the rectosigmoid
junction and rectum (36.8%). Despite the potential for chemo-
therapy and radiation therapy misclassification due to unknown
therapy information, we noted differences in uptake of radiation
therapy, chemotherapy, and surgery by early-onset CRC hot spot
classification in our study population (P # 0.001). Survival
among women with early-onset CRC did not significantly differ
by hot spot classification in adjusted models (see Table S2, Sup-
plementary Digital Content 2, http://links.lww.com/CTG/A447).
Patterns of community health behaviors by early-onset CRC
hot spot classification are presented in Table 2. Physical inactivity
and fertility as well as the county-level proportion of NHB indi-
viduals were county-level features modestly correlated with hot
spot residence (r 5 0.21, 20.23, and 0.26, respectively). On av-
erage, nearly one-quarter of adults residing in early-onset CRC
hot spots (24.1%) reported no leisure-time physical activity, 4.9%
of women (age 15–50 years) in early-onset CRC hot spot counties
had a live birth in the past year, and NHB individuals comprised
19.3% of the population in hot spot counties (Table 2).
Next, to quantify the total and individual variance explained
by these patient-level clinicodemographic and county-level
sociodemographic characteristics on early-onset CRC survival
among women, we used Cox proportional hazards regression
models (Figure 3 and see Table S3, Supplementary Digital Con-
tent 3, http://links.lww.com/CTG/A448). Although race and
ethnicity accounted for ,0.5% of variation in early-onset CRC
survival among women in non–hot spot counties, in hot spot
counties, this factor explained 1.4% of the variation in CRC-
specific survival among women with early-onset disease. Similar
patterns were observed for individual-level features including
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tumor histopathology (2.1% vs 0.8%, respectively) and age at
diagnosis (0.30% vs 0.09%), which explained greater variance in
CRC-specific survival among hot spot counties vs non–hot spot
counties. County-level proportions of the NHB population,
women (age 15–50 years) with a live birth in the last year, and
annual household income of ,$20,000 also explained greater
variance in cancer-specific survival among young women re-
siding in hot spot vs non–hot spot counties. Inversely, first course
of therapy (including surgery, radiation therapy, and chemo-
therapy) each explained greater variance among women with
early-onset CRC residing in non–hot spot counties vs hot spot
counties (Figure 3 and see Table S3, Supplementary Digital
Content 3, http://links.lww.com/CTG/A448). Irrespective of hot
spot classification, AJCC clinical stage explained nearly 30% of
variance in cancer-specific survival among women with early-
onset CRC. Moreover, assessment of multicollinearity reported
no evidence of high collinearity between tumor stage (variance
inflation factor [VIF] 5 1.03), chemotherapy (VIF 5 1.20), and
radiation (VIF5 1.18) (data not shown). Together, patient-level
clinicodemographic and county-level sociodemographic features
combined to account for one-third (34.0%) of the variation in
early-onset CRC survival among women (see Table S3, Supple-
mentary Digital Content 3, http://links.lww.com/CTG/A448). By
hot spot classification, these factors accounted for different
proportions of variance in early-onset CRC survival among
women residing in hot spot vs non–hot spot counties (33.8% vs
34.1%, respectively), although more than 60% of variance in
early-onset CRC survival among women (66.2% in hot spot
counties and 65.9% in non–hot spot counties) remained
unexplained.
DISCUSSION
Our analysis of the variation in CRC survival accounted for by
individual-level and community-level characteristics among
28,790 women diagnosed with a first primary invasive cancer
before age 50 years revealed distinct variance patterns in early-
onset CRC survival by geographic region (hot spot vs non–hot
spot counties). In addition, physical inactivity and fertility were
community health behaviors that moderately correlated with hot
spot residence among women diagnosed with early-onset CRC.
Our study is the first to define areas of high early-onset CRC
mortality (hot spots) in the contiguous United States among
women, an analysis undertaken to minimize sex differences in
early-onset CRC-specific outcomes, and to assess factors associ-
ated with geographic variation in early-onset CRC survival
among women in the United States.
Chronic physical inactivity and excess caloric intake lead to
energy imbalance, which over time results in the development of
Figure 1. Composition of study population and data sources for this study. CDC, Centers for Disease Control and Prevention; CRC, colorectal cancer; FIPS,
Federal Information Processing Standard; SEER, Surveillance, Epidemiology, and End Results.






Table 1. Summary of demographic and clinical characteristics by early-onset colorectal cancer hot spot counties in women diagnosed with
colorectal cancer: SEER 18, 1999–2016
Characteristic
Total (N 5 28,790)
Early-onset CRC county residence, N (%)
Hot spota (n5 3,954 [13.7]) Non–hot spot (n 5 24,836 [86.3])
P bN (%) or mean (SE)c N (%) or mean (SE)c N (%) or mean (SE)c
Age at diagnosis (%) 0.63
15–24 yr 717 (2.5) 112 (2.8) 605 (2.4)
25–29 yr 1,022 (3.5) 150 (3.8) 872 (3.5)
30–34 yr 2,094 (7.3) 279 (7.1) 1,815 (7.3)
35–39 yr 3,734 (13.0) 505 (12.8) 3,229 (13.0)
40–44 yr 7,248 (25.2) 999 (25.3) 6,249 (25.2)
45–49 yr 13,975 (48.5) 1,909 (48.3) 12,066 (48.6)
Mean, yr 42.4 (6.8) 42.4 (6.7) 42.3 (6.9) 0.26
Race/ethnicity (%) ,0.0001
Non-Hispanic white 16,800 (58.4) 2,279 (57.6) 14,521 (58.5)
Non-Hispanic black 4,497 (15.6) 936 (23.7) 3,561 (14.3)
Hispanic/Spanish/Latino 4,604 (16.0) 507 (12.8) 4,097 (16.5)
Otherd 2,889 (10.0) 232 (5.9) 2,657 (10.7)
AJCC stage 0.0003
0–I 4,777 (16.6) 632 (16.0) 4,145 (16.7)
II 4,853 (16.9) 731 (18.5) 4,122 (16.6)
III 7,241 (25.2) 952 (24.1) 6,289 (25.3)
IV 6,263 (21.8) 799 (20.2) 5,464 (22.0)
Unknown 5,656 (19.6) 840 (21.2) 4,816 (19.4)
Tumor site 0.29
Colon 18,199 (63.2) 2,529 (64.0) 15,670 (63.1)
Rectosigmoid junction/rectum 10,591 (36.8) 1,425 (36.0) 9,166 (36.9)
Histopathology 0.0001
Adenocarcinoma 21,690 (75.3) 2,883 (72.9) 18,807 (75.7)
Mucinous adenocarcinoma 2,357 (8.2) 331 (8.4) 2,026 (8.2)
Signet ring cell carcinoma 543 (1.9) 72 (1.8) 471 (1.9)
Other 4,200 (14.6) 668 (16.9) 3,532 (14.2)
Surgery 0.009
None 3,509 (12.2) 532 (13.5) 2,977 (12.0)
Yes 25,281 (87.8) 3,422 (86.6) 21,859 (88.0)
Radiation 0.001
None/unknown 23,535 (81.7) 3,310 (83.7) 20,225 (81.4)
Yes 5,255 (18.3) 644 (16.3) 4,611 (18.6)
Chemotherapy 0.0004
None/unknown 12,917 (44.9) 1,876 (47.5) 11,041 (44.5)
Yes 15,873 (55.1) 2,078 (52.6) 13,795 (55.5)
AJCC, American Joint Committee on Cancer; ANOVA, analysis of variance; CRC, colorectal cancer; SEER, Surveillance, Epidemiology, and End Results.
aPatients residing in counties with high rates of early-onset colorectal cancer mortality (fulfilling all 3 criteria for geographic clustering).
bSignificance determined using x2, ANOVA, or Wilcoxon rank-sum test as appropriate. P value calculations exclude unknown values.
cPresented as N (column percentage) or mean (SE).
dOther race/ethnicity includes American Indian/Alaska Native; Asian or Pacific Islander; or unknown.
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obesity—a risk factor for early-onset CRC among women (5) and
a prognostic factor of poor outcomes among patients diagnosed
with gastrointestinal cancers (7). In this study, we revealed that
physical inactivity was modestly and positively correlated with
areas of high early-onset CRC mortality among women—
approximately one-quarter of adults reported no leisure-time
physical activity in hot spot vs one-fifth of adults in non–hot spot
counties. In addition, female early-onset CRC hot spot counties
were also composed of a higher proportion of NHB individuals
compared with non–hot spot counties. Geographically, the
highest prevalence of physical inactivity andpoverty rates (23,24),
the greatest proportion of the US black population (25), as well as
a disproportionately high burden of chronic diseases (e.g., di-
abetes and cardiovascular disease) have been reported in the
SouthernUnited States—a region that accounts for 53% of female
early-onset CRC hot spots in our study. Racial/ethnic disparities
in physical inactivity persist amongUS adults; however, low levels
of leisure-time physical activity in black Americans are almost
entirely explained by poverty (26). Given the strong association
between obesity and income poverty level (27,28), together with
pronounced racial/ethnic disparities in obesity, physical in-
activity, and early-onset CRC outcomes, counties with lower SES
and reduced access to caremay lend to early-onset CRCdiagnosis
at later stages. The differences in variance of early-onset CRC
survival among women by hot spot classification that is explained
by first course of therapy regimen may in part be attributable to
differences in receipt of treatment across geographic regions.
Although we are limited in our ability to interpret these findings
given inherent potential for misclassification of missing data in
SEER (e.g., women classified as not having received
chemotherapy/radiation therapy when those data were actually
not recorded/captured), this difference may be explained by
community-level factors, including high-quality healthcare ac-
cess, urban density, distance to care provider, and residential
setting (29–31). Consequently, studies designed to distinguish
possible bidirectional causality between community health
behaviors/sociodemographics and women diagnosed with early-
onset CRC are also warranted. Together, these findings may in-
form cancer prevention/intervention strategies tailored to young
patients and may ultimately help to inform knowledge to reverse
early-onset CRC incidence trends and improve patient outcomes.
Additional studies to examine early-onset CRC incidence pat-
terns by hot spot classification among women will be helpful to
discern whether disease incidence rates are higher in regions with
disproportionately high early-onset CRC mortality.
For all-comers diagnosed with CRC, previous studies—
including reports leveraging spatial mapping methodology—
have indicated that CRC death rates are highest in Appalachia
Table 2. Patterns of community health behaviors by female early-onset colorectal cancer hot spot classification among women diagnosed
with colorectal cancer: SEER 18 linked with American Community Survey and County Health Rankings county-level data
County-level characteristic
Early-onset CRC county residence
Hot spotsa (N 5 3,954) Non–hot spots (N 5 24,836)
P b Correlation (rc)Presented as mean (SE)
Race/ethnicity
% Non-Hispanic white 57.8 (0.29) 54.8 (0.13) ,0.01 0.06
% Non-Hispanic black 19.3 (0.25) 11.5 (0.09) ,0.01 0.26
% Hispanic 15.1 (0.17) 22.2 (0.11) ,0.01 20.09
% Household income ,$20,000/yr 15.1 (0.07) 17.5 (3.9) ,0.01 20.12
Food environment index 7.9 (0.02) 7.5 (0.01) ,0.01 0.19
% Obesity 25.2 (0.07) 26.4 (0.03) ,0.01 20.07
% Smoking 15.9 (0.04) 15.7 (0.03) ,0.01 0.09
% Completed college 35.5 (0.16) 29.3 (6.6) ,0.01 0.19
% Physical inactivity 24.1 (0.05) 21.7 (0.03) ,0.01 0.21
% Unemployment 9.4 (0.03) 9.2 (0.01) ,0.01 0.06
% Uninsured 15.9 (0.07) 18.4 (0.03) ,0.01 20.17
PCP per 100,000 persons 82.9 (0.38) 73.6 (0.17) ,0.01 20.13
% Nonurban (rural) 5.4 (0.14) 14.9 (0.14) ,0.01 20.15
% Foreign born 1.02 (0.01) 0.97 (0.01) ,0.01 0.04
% Women aged 15–50 yr with a live birth in
past year
4.9 (0.01) 5.4 (0.01) ,0.01 20.23
CRC, colorectal cancer; ANOVA, analysis of variance; FIPS, Federal Information Processing Standard; PCP, primary care physician; SEER, Surveillance, Epidemiology, and
End Results.
aCounty characteristic determined by the patient FIPS code. Patients residing in counties with high early-onset colorectal cancer mortality (fulfilling all 3 criteria for
geographic clustering).
bSignificance determined using ANOVA or Wilcoxon test.
cSpearman correlation with being a county-level early-onset CRC mortality hot spot.






and areas of the South (32). Our findings among young women
are consistent with these geographic disparities in CRCmortality
among individuals of all ages. By contrast, our results differ from
breast cancermortality hot spots amongwomen—because 53%of
female early-onset CRC hot spot counties vs 72.5% of female
breast cancer hot spot counties were in the South (16). Strikingly,
a recent study of hot spots in early-onset CRC mortality aggre-
gated for both men and women between 1999 and 2017 revealed
that 92% of hot spot counties were in the Southern United States.
(33). Yet from 1980 to 2018, we report a marked shift in female
early-onset CRC hot spots because nearly half of all female hot
spot counties were in the Midwest and Northeast regions of the
United States, including northern Appalachia. Furthermore,
there persists a strong differential impact of socioeconomic status
on overall well-being, quality of life, income, and psychological
and physical health, by sex. Poverty rates for all groups of adult
women are higher than for their male counterparts (34), women
with low income are more likely to develop alcohol and drug
additions influenced by the social stressors linked to poverty (35),
and the effects of pregnancy on work/educational opportunities
and costs associated for pregnancy are higher for women than
men (36). Together, these factorsmay uniquely contribute to sex-
specific disparities in early-onset cancer etiology and outcomes
(3), including differences in community-level features by sex, and
are critical to unravel the underpinnings of the early-onset CRC
epidemic.
The use of data from the population-based SEER registry
program is a strength of this study because it allowed for a large
number of pathologically verified cases to be identified among
women across the United States with standardized 5-year follow-
up. However, we acknowledge the inherent limitations in cancer
registry data. One weakness of this study is that state-level colo-
noscopy data for this population could not be assessed. Although
CRC screening among individuals younger than 49 years was not
considered routine during our study period, differences in colo-
noscopy screening could partly contribute to variations in early-
onset CRC survival among women. However, recent reports—
which indicate that trends in colonoscopy screening do not fully
align with early-onset CRC incidence patterns—further suggest
the rising early-onset CRC burden is not fully explained by
screening practices (37). We also acknowledge the inability to
assess changes in female early-onset CRCmortality hot spots over
time due to CDC data limitations at the county level (CDC data
are suppressed at the county level when there are fewer than 10
deaths). SEER also lacks data on patient-level characteristics that
can impact young patient outcomes, such as comorbid conditions
(e.g., diabetes and insulin use) (38), comprehensive tumor his-
topathology and molecular phenotypes (e.g., microsatellite
Figure 2. Early-onset colorectal cancer survival hot spot regions: Centers for Disease Control and Prevention (CDC), 1980–2017. Pop, population.
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instability and somatic mutations), body mass index, history of
gastrointestinal polyps, family history of cancer, and individual-
level socioeconomic factors. However, use of county-level pro-
portions of the population with an annual household income
,$20,000 as a proxy for socioeconomic status allowed us to ex-
plore potential differences in healthcare access that may con-
tribute to geographic disparities in CRC outcomes. Although our
findings raise the possibility that these individual/community-
level features uniquely contribute to variation in early-onset CRC
survival by geographic region, we are unable to provide evidence
for causation between these features and early-onset CRC out-
comes among women given the ecologic design of the study.
In summary, our findings emphasize the importance of
defining patterns of variance in early-onset CRC survival to
understand the impact of community health behaviors on
early-onset CRC outcomes. We observed that physical in-
activity and fertility were community health behaviors that
modestly correlated with regions of high early-onset CRC
mortality among women. We also observed that individual-
and community-level factors accounted for approximately
one-third of the variation in early-onset CRC survival among
women and yielded distinct patterns by hot spot residence.
Further study of community health behaviors and healthcare
access, as well as modifiable CRC risk factors, is critical to
elucidate the unexplained variance in early-onset CRC survival
among women in the United States—particularly in counties
with high rates of early-onset CRC mortality—to reduce dis-
parities in the early-onset CRC burden and improve young
patient outcomes.
CONFLICTS OF INTEREST
Guarantor of the article: Andreana N. Holowatyj, PhD, MS.
Specific author contributions: A.N.H. and J.X.M.: had full access to
all of the data in the study and take responsibility for the integrity of
the data and the accuracy of the data analysis. A.N.H., M.L., Y.H.,
R.V., and J.X.M.: contributed to the planning and conducting the
study, collecting and interpreting data, and drafting/critical revision
of the manuscript. All authors participated in the interpretation of
data and drafting and critical revision of the manuscript for impor-
tant intellectual content. A.N.H. and J.X.M.: obtained funding and
provided support and supervision for this study.
Financial support: A. N. Holowatyj was supported by the
Department ofMedicine at theVanderbiltUniversityMedical Center
and the National Institutes of Health (NIH) under Ruth L.
Kirschstein National Research Service Award T32 HG008962 from
theNational HumanGenomeResearch Institute. M. E. Langstonwas
supported by the National Institutes of Health K12 DK111028 from
theNational Institute of Diabetes andDigestive andKidneyDiseases.
Figure 3. Generalized R2 values for independently fit models among women with early-onset CRC by hot spot classification using the Cox proportional
hazards regression: SEER 18 linked with American Community Survey and County Health Rankings county-level data. R2 values represent the variance
explained by each independent factor. ACS, American Community Survey; AJCC, American Joint Committee on Cancer; CRC, colorectal cancer; SEER,
Surveillance, Epidemiology, and End Results.






R. Viskochil was supported by the “Driving out Diabetes: A Larry H.
Miller FamilyWellness Initiative.”Y. Cao was supported byNational
Cancer Institute K07 CA218377. C. R. Rogers was supported by
National Cancer Institute K01 CA234319. J. X.Moore was supported
by a training grant from theNational Cancer Institute of theNational
Institutes of Health under award number T32 CA190194. This work
was also supported by the Huntsman Cancer Foundation and the
ACSM Paffenbarger-Blair Fund for Physical Activity Epidemiology.
The content is solely the responsibility of the authors and does not
necessarily represent the official views of the NIH or the Driving
out Diabetes: A Larry H. Miller Family Wellness Initiative. A. N.
Holowatyj was also supported by the National Institutes of Health
K12 HD043483 from the Eunice Kennedy Shriver National Institute
of Child Health and Human Development.
Potential competing interests: None to report.
Study Highlights
WHAT IS KNOWN
3 CRC incidence rates are rising for men and women younger
than 50 years (early-onset) with unknown etiologies.
3 Disparities in survival among patients with early-onset CRC
persist by sex.
3 The role of health behaviors on CRC outcomes among young
women remains unknown.
WHAT IS NEW HERE
3 Wedefined areas of high early-onset CRCmortality (hot spots)
among women at the county level using geospatial
methodology.
3 Approximately 1 in every 16 contiguous US counties
identified as early-onset CRC hot spots among women—53%
of hot spot counties were located in the South.
3 Proportions of physical inactivity and fertility were community
health behaviors that modestly correlated with hot spot
residence among women with early-onset CRC.
3 Individual/community-level features together accounted for
one-third of variance in early-onset CRC survival among
women.
3 Individual/community-level features accounted for distinct
variance patterns in early-onset CRC survival among women.
TRANSLATIONAL IMPACT
3 Understanding the impact of community health behaviors is
critical for tailoring strategies to reduce early-onset CRC
disparities, particularly among women.
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